Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16
Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Tuesday, October 3rd, Wall Street Journal reports. Stockholders of record on Thursday, November 30th will be given a dividend of 0.16 per share by the medical instruments supplier on Friday, December 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Wednesday, November 29th.
Mesa Laboratories has increased its dividend payment by an average of 3.9% per year over the last three years. Mesa Laboratories has a dividend payout ratio of 24.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $3.40 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 18.8%.
Shares of Mesa Laboratories (MLAB) traded up 0.67% on Tuesday, hitting $152.50. The stock had a trading volume of 10,166 shares. The firm has a 50 day moving average of $138.50 and a 200-day moving average of $140.07. Mesa Laboratories has a 1-year low of $109.14 and a 1-year high of $169.81. The firm has a market capitalization of $573.10 million, a price-to-earnings ratio of 54.82 and a beta of 0.48.
Mesa Laboratories (NASDAQ:MLAB) last issued its earnings results on Monday, July 31st. The medical instruments supplier reported $0.39 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.17). Mesa Laboratories had a return on equity of 16.58% and a net margin of 11.31%. The firm had revenue of $22.67 million during the quarter, compared to analysts’ expectations of $22.90 million. Equities analysts predict that Mesa Laboratories will post $2.74 earnings per share for the current year.
A number of brokerages have issued reports on MLAB. Zacks Investment Research raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating and set a $159.00 price target on the stock in a report on Tuesday, June 13th. TheStreet downgraded shares of Mesa Laboratories from a “b” rating to a “c+” rating in a research note on Monday, July 31st. Finally, BidaskClub downgraded shares of Mesa Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, July 31st.
In other Mesa Laboratories news, Director H Stuart Campbell sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $143.37, for a total transaction of $286,740.00. Following the completion of the transaction, the director now owns 49,976 shares of the company’s stock, valued at approximately $7,165,059.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders have sold 8,610 shares of company stock worth $1,176,809. 15.70% of the stock is owned by company insiders.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.